PharmaLEDA
ActiveSummary
The computed 12-month bankruptcy probability of PharmaLEDA is 3.1% (moderate). The 2025 annual accounts show equity of €189,174 and a net result of €59,554. Equity is growing by ~43.3% per year across the filed fiscal years. Its solvency ranks better than 29% of 10485 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability52▲+1
Solvency44▲+6
Growth78=
Track record94
Bankruptcy probability, 12 months
3.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €8,000 at 30 days acceptable
Liquidity short (current ratio 0.06 against 0.04 in 2024; short-term debt: 43.3% and cash: 0.5% of total assets), and 81.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
18.7%
Return on assets
5.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
25 d early
2024
27 d early
2023
2 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 3 accounts on average 17 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€59,554▲ 9.8%
2024 · €54,223
Working capital
-€412,931▲ 1.2%
2024 · -€417,763
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line202320242025
Operating result€61,229-€87,096▲ 42.2%€91,790▲ 5.4%
Net result€31,230within the sector's middle half-€54,223within the sector's middle half▲ 73.6%€59,554within the sector's middle half▲ 9.8%
Equity€76,230within the sector's middle half-€130,453within the sector's middle half▲ 71.1%€189,174within the sector's middle half▲ 45.0%
Total assets€1.1mwithin the sector's middle half-€1.0mwithin the sector's middle half▼ 5.5%€1.0mwithin the sector's middle half▲ 0.8%
Debt€986,360-€873,592▼ 11.4%€823,046▼ 5.8%
Working capital-€419,989--€417,763▲ 0.5%-€412,931▲ 1.2%
Solvency7.2%below the sector's middle half-13.0%below the sector's middle half▲ 5.8pp18.7%within the sector's middle half▲ 5.7pp
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 5% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.0m
Fixed assets
€986,509 =
Current assets
€25,711 ▲ 46.6%
Equity and liabilities €1.0m
Equity
€189,174 ▲ 45.0%
Debt
€823,046 ▼ 5.8%
Debt's share of the balance-sheet total falls from 87.0% to 81.3%. Equity is higher and debt is lower.
Key figures and ratios
Current ratio
0.06▲
2024 · 0.04
Debt to equity
4.35▼
2024 · 6.70
ROE
31.5%▼
2024 · 41.6%
ROA
5.9%▲
2024 · 5.4%
Debt ≤ 1 year
€438,642▲
2024 · €435,298
Debt > 1 year
€383,044▼
2024 · €436,774
Income taxes
€14,888▲
2024 · €13,556
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Other operating charges640/8 | €384 | €792 | €1,010 | ▲ 27.5% |
| Gross operating margin9900 | €61,613 | €87,888 | €92,800 | ▲ 5.6% |
| Operating profit (loss)9901 | €61,229 | €87,096 | €91,790 | ▲ 5.4% |
| Financial charges65/66B | €22,191 | €19,317 | €17,348 | ▼ 10.2% |
| Recurring financial charges65 | €22,191 | €19,317 | €17,348 | ▼ 10.2% |
| Profit (loss) for the period before taxes9903 | €39,037 | €67,779 | €74,442 | ▲ 9.8% |
| Income taxes67/77 | €7,807 | €13,556 | €14,888 | ▲ 9.8% |
| Profit (loss) for the period9904 | €31,230 | €54,223 | €59,554 | ▲ 9.8% |
| Profit (loss) for the period to be appropriated9905 | €31,230 | €54,223 | €59,554 | ▲ 9.8% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €1.1m | €1.0m | €1.0m | ▲ 0.8% |
| Fixed assets21/28 | €986,509 | €986,509 | €986,509 | = |
| Financial fixed assets28 | €986,509 | €986,509 | €986,509 | = |
| Current assets29/58 | €76,080 | €17,536 | €25,711 | ▲ 46.6% |
| Amounts receivable within one year40/41 | €49,968 | €8,637 | €21,036 | ▲ 144% |
| Trade receivables40 | €42,775 | - | €20,924 | - |
| Other amounts receivable41 | €7,193 | €8,637 | €112 | ▼ 98.7% |
| Cash at bank and in hand54/58 | €26,112 | €8,899 | €4,675 | ▼ 47.5% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €1.1m | €1.0m | €1.0m | ▲ 0.8% |
| Equity10/15 | €76,230 | €130,453 | €189,174 | ▲ 45.0% |
| Contributions10/11 | €45,000 | €45,000 | €45,000 | = |
| Profit (loss) carried forward14 | €31,230 | €85,453 | €144,174 | ▲ 68.7% |
| Amounts payable17/49 | €986,360 | €873,592 | €823,046 | ▼ 5.8% |
| Amounts payable after more than one year17 | €488,617 | €436,774 | €383,044 | ▼ 12.3% |
| Financial debts170/4 | €488,617 | €436,774 | €383,044 | ▼ 12.3% |
| Amounts payable within one year42/48 | €496,070 | €435,298 | €438,642 | ▲ 0.8% |
| Current portion of amounts payable after more than one year42 | €69,111 | €71,080 | €73,121 | ▲ 2.9% |
| Trade debts44 | €807 | €1,205 | €633 | ▼ 47.5% |
| Suppliers440/4 | €807 | €1,205 | €633 | ▼ 47.5% |
| Taxes, remuneration and social security45 | €7,769 | €4,615 | €5,657 | ▲ 22.6% |
| Taxes450/3 | €7,769 | €4,615 | €5,657 | ▲ 22.6% |
| Other amounts payable47/48 | €418,383 | €358,398 | €359,231 | ▲ 0.2% |
| Accrued charges and deferred income492/3 | €1,673 | €1,519 | €1,360 | ▼ 10.5% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €31,230 | €54,223 | €59,554 | ▲ 9.8% |
| Operating cash flow (approximation) | €31,230 | €54,223 | €59,554 | ▲ 9.8% |
| Investment in fixed assets (approximation) | - | €0 | €0 | - |
| Change in cash | - | -€17,213 | -€4,224 | ▲ 75.5% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2023net €59,554 ▲9.8%
Operating result €91,790, net result €59,554, both a record.
31-12
Financial
Equity above €150,000Eq €189,174 ▲45%
3 profitable years in a row build equity to €189,174.
04-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Equity above €100,000Eq €130,453 ▲71.1%
2 profitable years in a row build equity to €130,453.
02-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2022
Ground area
661 m²
Building footprint
607 m²
Volume, LiDAR
18,813 m³
Parcel 21447B0313/00D023, Brussels · tallest building 36.9 m, ±11 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
PharmaLEDA
since 20222.338.374.644
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21447B0313/00D023 | Brussels | 661 m² | 1 · 607 m² | 36.9 m · 11 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
100%
According to the 2025 annual accounts of PharmaLEDA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
Pharmacie du Chenois
BE 0502.451.090
Waterloo · Eq €189,196
PHARMACIE NAIM
BE 0432.596.739
Saint-Nicolas · Eq €189,212
APOTHEEK GOOSSENS-DE TURCK
BE 0859.604.496
Lebbeke · Eq €189,250
APOTHEEK MEES HAACHT STATION
BE 0860.236.283
Haacht · Eq €189,353
APOTHEEK STAEREN-CORION
BE 0420.528.256
Sint-Laureins · Eq €189,372
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,567 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-10-2022
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Contact
E-mail
kelouari@gmail.com
Phone
+32487572547
E-invoicing
Reachable via Peppol
Peppol ID
0208:0792415863
Also
9925:BE0792415863
Registered
30-12-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.